Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
$6,304.00
$0.00
$0.00
N/AN/AN/A8,370 shs
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$8.81
+5.0%
C$8.04
C$3.11
C$9.98
C$211.35M0.9740,582 shs52,559 shs
Indiva Limited stock logo
NDVA
Indiva
C$0.07
+16.7%
C$0.08
C$0.02
C$0.13
C$13.67M1.1199,304 shs87,606 shs
WeedMD Inc. stock logo
WMD
WeedMD
C$0.28
-1.8%
C$0.28
C$0.23
C$0.99
C$67.82MN/A766,591 shs271,436 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
0.00%0.00%0.00%0.00%0.00%
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
-1.29%-9.98%-8.41%+47.19%+147.49%
Indiva Limited stock logo
NDVA
Indiva
0.00%-14.29%-25.00%-36.84%-14.29%
WeedMD Inc. stock logo
WMD
WeedMD
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Indiva Limited stock logo
NDVA
Indiva
N/AN/AN/AN/AN/AN/AN/AN/A
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
3.00
BuyC$8.00-9.19% Downside
Indiva Limited stock logo
NDVA
Indiva
3.00
BuyC$0.15114.29% Upside
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/A

Current Analyst Ratings

Latest NDVA, VLG, ASP, WMD, and CPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/14/2024
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSpeculative Buy ➝ BuyC$4.75 ➝ C$8.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$21.16M9.99C$2.50 per share3.53C$3.36 per share2.62
Indiva Limited stock logo
NDVA
Indiva
C$36.01M0.38C$0.01 per share5.20N/A
WeedMD Inc. stock logo
WMD
WeedMD
C$27.53M2.46C$0.08 per share3.27C$0.34 per share0.81

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$20.38MC$1.098.08N/A96.32%28.19%8.06%5/9/2024 (Estimated)
Indiva Limited stock logo
NDVA
Indiva
-C$6.94M-C$0.05N/AN/A-19.27%-288.64%-6.91%5/14/2024 (Estimated)
WeedMD Inc. stock logo
WMD
WeedMD
N/A-C$0.42N/AN/AN/AN/AN/AN/A

Latest NDVA, VLG, ASP, WMD, and CPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/14/2024Q4 2023
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$0.15C$0.41+C$0.26C$0.41C$7.31 millionC$6.70 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/A
Indiva Limited stock logo
NDVA
Indiva
N/AN/AN/AN/AN/A
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
0.44
9.19
2.67
Indiva Limited stock logo
NDVA
Indiva
5,899.22
0.85
0.52
WeedMD Inc. stock logo
WMD
WeedMD
95.63
3.46
1.46

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.03%
Indiva Limited stock logo
NDVA
Indiva
0.33%
WeedMD Inc. stock logo
WMD
WeedMD
N/A

Insider Ownership

CompanyInsider Ownership
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
44.73%
Indiva Limited stock logo
NDVA
Indiva
36.29%
WeedMD Inc. stock logo
WMD
WeedMD
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Strategic Income Portfolio Inc. stock logo
ASP
American Strategic Income Portfolio
N/AN/AN/ANot Optionable
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
523.99 millionN/ANot Optionable
Indiva Limited stock logo
NDVA
Indiva
147,000195.30 millionN/ANot Optionable
WeedMD Inc. stock logo
WMD
WeedMD
212246.62 millionN/ANot Optionable

NDVA, VLG, ASP, WMD, and CPH Headlines

SourceHeadline
Truth about WMD will finally emerge'Truth about WMD will finally emerge'
dailymail.co.uk - March 4 at 8:18 AM
No cabinet submission on costs, benefits, implications of going to war in IraqNo cabinet submission on costs, benefits, implications of going to war in Iraq
theaustralian.com.au - January 3 at 1:15 PM
Blair: Saddam still has weapons of mass destructionBlair: 'Saddam still has weapons of mass destruction'
dailymail.co.uk - October 5 at 12:01 AM
Bush administration retreats on WMD claimBush administration retreats on WMD claim
namibian.com.na - August 29 at 6:28 AM
Missing WMD ‘hurting war on terror’Missing WMD ‘hurting war on terror’
namibian.com.na - August 29 at 6:28 AM
Weapons of Mass Destruction and the ethics of their usageWeapons of Mass Destruction and the ethics of their usage
arstechnica.com - August 17 at 11:16 PM
Russia used sabotaged dam as ‘weapon of mass destruction’ says UkraineRussia used sabotaged dam as ‘weapon of mass destruction’ says Ukraine
politico.eu - June 12 at 4:56 PM
US, South Korea issue fresh North Korea sanctions on illicit IT workforceUS, South Korea issue fresh North Korea sanctions on 'illicit' IT workforce
asahi.com - May 27 at 11:26 PM
Malaysia Gets Tough on WMDMalaysia Gets Tough on WMD
thediplomat.com - May 27 at 11:26 PM
Interpol Tackles WMD TerrorismInterpol Tackles WMD Terrorism
thediplomat.com - May 21 at 5:30 PM
Weapons of mass destruction found'Weapons of mass destruction found'
dailymail.co.uk - May 20 at 3:39 PM
Chemical Weapons are NOT WMDsChemical Weapons are NOT WMDs
thediplomat.com - May 17 at 6:51 PM
The Next Financial WMD?The Next Financial WMD?
thestreet.com - May 14 at 11:37 PM
The Week in Weed – May 6, 2023 - StratCannThe Week in Weed – May 6, 2023 - StratCann
news.google.com - May 6 at 3:33 PM
WMD in Iraq: Evidence and ImplicationsWMD in Iraq: Evidence and Implications
medscape.com - April 28 at 10:49 AM
What happened when WMD experts tried to make the GPT-4 AI do bad thingsWhat happened when WMD experts tried to make the GPT-4 AI do bad things
thebulletin.org - April 2 at 12:38 AM
Mass DestructionMass Destruction
bostonreview.net - March 31 at 1:34 PM
Bush’s Iraq War Lies Created a Blueprint for Donald TrumpBush’s Iraq War Lies Created a Blueprint for Donald Trump
theintercept.com - March 22 at 8:37 AM
Column: The road to war: An ex-Reuters journalist recalls the chase for WMD in IraqColumn: The road to war: An ex-Reuters journalist recalls the chase for WMD in Iraq
reuters.com - March 22 at 8:37 AM
So where were they, Mr Blair? How The Independent exposed the lie of Saddam’s WMD and the justification for an illegal warSo where were they, Mr Blair? How The Independent exposed the lie of Saddam’s WMD and the justification for an illegal war
independent.co.uk - March 22 at 8:37 AM
WMD Inspector: Bush should have faced war crimes court over Iraq invasionWMD Inspector: Bush should have faced war crimes court over Iraq invasion
msnbc.com - March 22 at 8:37 AM
The Biden administration overestimates radiological terrorism risks and underplays biothreatsThe Biden administration overestimates radiological terrorism risks and underplays biothreats
thebulletin.org - March 20 at 12:32 AM
Middle East ProgramMiddle East Program
csis.org - February 11 at 7:33 AM
Former WeedMD employee, ex-mutual fund dealer fined for stock scheme - The London Free PressFormer WeedMD employee, ex-mutual fund dealer fined for stock scheme - The London Free Press
news.google.com - January 15 at 8:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

American Strategic Income Portfolio logo

American Strategic Income Portfolio

NYSE:ASP
American Strategic Income Portfolio Inc. (ASP) invests in mortgage-related assets that directly or indirectly represent a participation in or are secured by and payable from mortgage loans. The Fund may also invest in the United States Government securities, corporate debt securities, preferred stock issued by real estate investment trusts, and mortgage servicing rights. In addition, the Fund may borrow using reverse repurchase agreements and credit facilities. The Fund's primary objective is to achieve high levels of current income. Its secondary objective is to seek capital appreciation. The Barclays Capital Mutual Fund Government/Mortgage Index, ASP's benchmark, consists of all the United States Government agency and Treasury securities and agency mortgage-backed securities. The Fund's investment advisor is U.S. Bancorp Asset Management, Inc. ASP's sub-advisors include Nuveen Asset Management, LLC and Nuveen Fund Advisors, Inc.
Cipher Pharmaceuticals logo

Cipher Pharmaceuticals

TSE:CPH
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
Indiva logo

Indiva

CVE:NDVA
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
WeedMD logo

WeedMD

CVE:WMD
WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.